KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Buildings (2016 - 2025)

Gilead Sciences filings provide 16 years of Buildings readings, the most recent being $4.6 billion for Q4 2025.

  • On a quarterly basis, Buildings rose 1.83% to $4.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $4.6 billion, a 1.83% increase, with the full-year FY2025 number at $4.6 billion, up 1.83% from a year prior.
  • Buildings hit $4.6 billion in Q4 2025 for Gilead Sciences, up from $4.5 billion in the prior quarter.
  • In the past five years, Buildings ranged from a high of $4.6 billion in Q4 2025 to a low of $3.8 billion in Q4 2021.
  • Median Buildings over the past 5 years was $4.4 billion (2022), compared with a mean of $4.3 billion.
  • Biggest five-year swings in Buildings: grew 15.71% in 2022 and later dropped 1.41% in 2023.
  • Gilead Sciences' Buildings stood at $3.8 billion in 2021, then increased by 15.71% to $4.4 billion in 2022, then fell by 1.41% to $4.3 billion in 2023, then rose by 4.88% to $4.5 billion in 2024, then rose by 1.83% to $4.6 billion in 2025.
  • The last three reported values for Buildings were $4.6 billion (Q4 2025), $4.5 billion (Q4 2024), and $4.3 billion (Q4 2023) per Business Quant data.